SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Market Cap	3.22B -31.7%
Revenue (ttm)	1.30B +3.4%
Net Income	261.61M -33.5%
EPS	5.85 -33.5%
Shares Out	44.59M
PE Ratio	12.32
Forward PE	n/a
Dividend	4.00 (5.55%)
Ex-Dividend Date	Jul 21, 2025

Volume	29,625
Average Volume	24,653
Open	70.80
Previous Close	70.80
Day's Range	70.80 - 72.10
52-Week Range	70.00 - 95.10
Beta	-0.08
RSI	53.66
Earnings Date	Apr 2, 2026

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulc...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1982
• Employees: 223
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1777

Financial Performance

In 2025, SYN-TECH Chem. & Pharm.'s revenue was 1.30 billion, an increase of 3.39% compared to the previous year's 1.26 billion. Earnings were 261.61 million, a decrease of -33.48%.